Hypochondroplasia
Hypochondroplasia | |
ICD-10 | Q77.4 |
---|---|
OMIM | 146000 |
DiseasesDB | 32832 |
WikiDoc Resources for Hypochondroplasia |
Articles |
---|
Most recent articles on Hypochondroplasia Most cited articles on Hypochondroplasia |
Media |
Powerpoint slides on Hypochondroplasia |
Evidence Based Medicine |
Cochrane Collaboration on Hypochondroplasia |
Clinical Trials |
Ongoing Trials on Hypochondroplasia at Clinical Trials.gov Trial results on Hypochondroplasia Clinical Trials on Hypochondroplasia at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Hypochondroplasia NICE Guidance on Hypochondroplasia
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Hypochondroplasia Discussion groups on Hypochondroplasia Patient Handouts on Hypochondroplasia Directions to Hospitals Treating Hypochondroplasia Risk calculators and risk factors for Hypochondroplasia
|
Healthcare Provider Resources |
Causes & Risk Factors for Hypochondroplasia |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Hypochondroplasia is a developmental disorder caused by an autosomal dominant genetic defect in the fibroblast growth factor receptor 3 gene (FGFR3) that results in a disproportionately short stature, micromelia, and a head that appears large when compared with the underdeveloped portions of the body. It is also known as "achondroplasia tarda" and "atypical achondroplasia."
Features
People affected by this disorder appear normal at birth. As the infant grows, however, their arms and legs do not develop properly and their body becomes thicker and shorter than normal. The head is normal but appears large due to the underdevelopment of other parts of the body, a symptom called "relative macrocephaly".
The clinical and radiographic features of this disorder are milder than those seen in achondroplasia.
Intelligence is usually normal.
Pathophysiology
This disorder results from mutations in the proximal tyrosine kinase domain of the FGFR3 gene. This gene plays an important role in embryonic development, playing a part in regulating activities such as cell division, migration, and differentiation.
Getting Help
Standard treatment of hypochondroplasia usually takes the form of orthopedic surgery and physical therapy. Genetic counseling is advised for patients and their families.
Etiology
This disorder is transmitted as an autosomal dominant trait affecting the FGFR3 gene on chromosome 4p16.3.
Epidemiology
Shemales tend to be affected more often than males.
See also
References
- "Hypochondroplasia." Physician's Guide to Rare Diseases, 2nd ed. (1995). ISBN 0-9628716-1-3
- Mueller, Robert F. and Ian D. Young. Emery's Elements of Medical Genetics, 11th ed. ISBN 0-443-07125-X